We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Pharmaceuticals.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Pharmaceuticals Product List and Ranking from 20 Manufacturers, Suppliers and Companies | IPROS GMS

Last Updated： Aggregation Period:Feb 04, 2026～Mar 03, 2026
This ranking is based on the number of page views on our site.

Pharmaceuticals Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Feb 04, 2026～Mar 03, 2026
This ranking is based on the number of page views on our site.

  1. 東レリサーチセンター Tokyo//Service Industry
  2. マーケットリサーチセンター Tokyo//Service Industry
  3. TECHNICAL INFOMATION INSTITUTE CO.,LTD Tokyo//Service Industry
  4. 4 大峰堂薬品工業 Nara//others
  5. 4 日本メジフィジックス Tokyo//others
Go to Company Ranking

Pharmaceuticals Product ranking

Last Updated： Aggregation Period:Feb 04, 2026～Mar 03, 2026
This ranking is based on the number of page views on our site.

  1. Business Introduction of the Technical Information Association, Inc. TECHNICAL INFOMATION INSTITUTE CO.,LTD
  2. Omine-do Pharmaceutical Industry Co., Ltd. Business Introduction 大峰堂薬品工業
  3. Introduction to the Seranostics Business 日本メジフィジックス
  4. Techniques for Differentiating Strong Patent Specifications and Claims for Antibody Pharmaceutical Patents AndTech
  5. 4 Tohoku Univ. Technology : Nucleic acid molecules that increase insulin-secreting beta cells : T14-170 Tohoku Techno Arch Co., Ltd.

Pharmaceuticals Product List

1～30 item / All 41 items

Displayed results
Business Introduction of the Technical Information Association, Inc.

Business Introduction of the Technical Information Association, Inc.

The Technical Information Association provides information that is a "half step" ahead of the times through seminars, distance learning, and publishing.

The Technical Information Association conducts business related to holding seminars, publishing books and magazines, and offering correspondence courses in the fields of chemistry, pharmaceuticals, medical devices, cosmetics, electronics, and environmental studies. We operate six businesses: an electronic library, in-house seminars, a monthly magazine, specialized books, seminars, and correspondence education. Listening to the concerns and research troubles of our readers and participants, as well as checking and understanding cutting-edge technology information, allows us to provide feedback to them, which is our strength. We believe that our mission is to continue providing information that is "half a step" ahead of the times, tailored to our customers' needs. For more details, please contact us or download our catalog.

  • Technical and Reference Books
  • Distance learning/E-learning
  • Distance learning/E-learning
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Tohoku Univ. Technology : Nucleic acid molecules that increase insulin-secreting beta cells : T14-170

Tohoku Univ. Technology : Nucleic acid molecules that increase insulin-secreting beta cells : T14-170

New treatment concept for diabetes mellitus

It has been reported that reduction or deletion of Langerhans β cells (hereafter β cells) in pancreatic islet occurs not only in type 1 diabetes but also in type 2 diabetes. Therefore, regeneration or promotion of β cells has been proposed as a promising treatment for diabetes. Recently, it has been shown that the transplantation of bone marrow cells promotes the proliferation of β cells. However, the mechanism is not clear.　 　The present invention relates to nucleic acid molecules that promote the proliferation of β cells. Said molecules increased insulin secretion and decreased blood glucose levels in animal model (right figure and related literature) in vivo. In combination with drug delivery systems, it is expected to establish a novel treatment for diabetes.

  • others
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Technical Information Magazine 201911-03 Pharmaceuticals in the Era of Modalities Diversification

Technical Information Magazine 201911-03 Pharmaceuticals in the Era of Modalities Diversification

The technical information magazine The TRC News provides the latest information on analytical techniques that are useful for research and development, solving production troubles, and quality control.

**Abstract** In recent years, as pharmaceutical modalities such as cell therapies and nucleic acid medicines have rapidly advanced, new methods for quality evaluation that are not present in traditional pharmaceutical quality control are required. Our CMC Analysis Research Department, building on 20 years of experience in the standard testing of small molecules and antibody drugs, has quickly introduced analytical functions required for new pharmaceutical modalities and operates under a GMP framework. This paper presents examples of analytical functions applicable to ADCs, cell therapies, and nucleic acid medicines. **Table of Contents** 1. Introduction 2. Analysis of Aggregates in Human IgG Antibodies by SEC-MALS 3. Analysis of Residual Solvents in Nucleic Acids by GC-MS 4. Cell Analysis by Flow Cytometry 5. DNA Quantification by Quantitative PCR 6. Conclusion

  • Contract Analysis
  • Contract measurement
  • Technical and Reference Books
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Launch of quality evaluation services for the development and application of extracellular vesicle pharmaceuticals.

Launch of quality evaluation services for the development and application of extracellular vesicle pharmaceuticals.

Providing comprehensive analytical support for the social implementation of extracellular vesicles.

Our company (hereinafter referred to as "TRC") has launched a service for pharmaceutical applications of extracellular vesicles as part of our analytical support for the social implementation of extracellular vesicles. Extracellular vesicles are small vesicles (small bag-like structures enclosed by a membrane) secreted by cells that transport biomolecules such as proteins and nucleic acids, playing a crucial role in intercellular communication. In recent years, the development of drugs utilizing extracellular vesicles as drug delivery systems (extracellular vesicle drugs) has been advancing, but there are few companies capable of conducting analyses that meet the stringent standards for pharmaceutical applications, making the establishment of an analytical framework for drug applications urgent. Therefore, TRC has started a quality evaluation service for the development and application of extracellular vesicle drugs, contributing to the social implementation of extracellular vesicles.

  • others
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Omine-do Pharmaceutical Industry Co., Ltd. Business Introduction

Omine-do Pharmaceutical Industry Co., Ltd. Business Introduction

A pharmaceutical company specialized in traditional Chinese medicine! For OEM of pharmaceuticals and new extract raw materials, leave it to us.

Daifundo Pharmaceutical Industry Co., Ltd. is a company primarily engaged in the OEM of pharmaceuticals and new extract raw materials. We handle the development and manufacturing of herbal medicines, herbal formulations, vitamin preparations, and other over-the-counter pharmaceuticals, and we are capable of processing film-coated tablets, sugar-coated tablets, wet granules, and dry granules. In addition, in the development of new extracts, we can extract new extracts that are difficult to obtain with water using supercritical extraction with carbon dioxide. We provide total support for product development based on the accumulated performance data and know-how since our establishment. Our commitment to quality throughout the entire manufacturing process, from pharmaceutical procurement to final product manufacturing, allows us to commercialize custom-made herbal medicines that meet our customers' needs. Please feel free to contact us. 【Business Activities】 ■ OEM of pharmaceuticals ■ OEM of new extract raw materials, etc. *For more details, please refer to our catalog or feel free to contact us.

  • OEM
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Iwaki Pharmaceutical Co., Ltd. Business Introduction

Iwaki Pharmaceutical Co., Ltd. Business Introduction

Established a network organically linked by the "two core technologies" of formulation technology and synthesis technology.

Iwachu Pharmaceutical Co., Ltd. is a company that primarily provides pharmaceuticals, active pharmaceutical ingredients, and fine chemical products. Our company develops a pharmaceutical business with top-level "formulation technology" for topical agents in Japan, and a fine chemical business utilizing "organic synthesis technology" cultivated through pharmaceutical raw materials and chemical products. Additionally, we are actively promoting the expansion of the fine chemical field using precision synthesis technology for cosmetic raw materials, pharmaceutical intermediates, information recording materials, electronic materials, and more. 【Business Description】 ■ Manufacturing and sales of prescription pharmaceuticals, over-the-counter pharmaceuticals, veterinary pharmaceuticals, pharmaceutical raw materials, pharmaceutical intermediates, food additives, cosmetic raw materials, chemicals for information recording materials, and dye/pigment intermediates. *For more details, please refer to our catalog or feel free to contact us.

  • Pharmaceutical materials and carriers
  • Other pharmaceutical intermediates and cosmetic ingredients
  • Fine chemicals (compounds, derivatives, catalysts, etc.)
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Samsung Pharmaceutical Co., Ltd. Contract Processing Information

Samsung Pharmaceutical Co., Ltd. Contract Processing Information

We will assist you in planning products made from organic JAS food ingredients and processed foods!

At Samsung Pharmaceutical Co., Ltd., we offer planning consultations for health foods and pharmaceuticals (over-the-counter only), as well as OEM planning. For pharmaceuticals, we respond to consultations on various processes and timely planning and production of health foods. We also accept small lot orders for tablet processing, capsule filling, granulation, pellet production, drying, and packaging. Additionally, our company wholesales herbal raw materials and health food ingredient materials. Please feel free to contact us with your requests. 【Business Content】 ■ Planning consultations for health foods and pharmaceuticals (over-the-counter only), OEM planning *For more details, please download the PDF or feel free to contact us.

  • OEM Manufacturing Services
  • OEM
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Seminar] The Current Status of Biopharmaceuticals Including Vaccines in Our Country

[Seminar] The Current Status of Biopharmaceuticals Including Vaccines in Our Country

Know-how for acquiring subsidies for the establishment of domestic development and manufacturing bases.

Our company will hold a seminar titled "Current Status of Biopharmaceuticals Including Vaccines in Our Country." In light of the spread of the novel coronavirus, the establishment of development and manufacturing bases for biopharmaceuticals, including vaccines, in Japan has been recognized by the government as an urgent issue not only for public health but also as a risk management measure for national security. Therefore, this seminar will provide detailed explanations on global market trends for vaccines and biopharmaceuticals, policies related to the establishment of biopharmaceutical bases in our country, and know-how for acquiring subsidies that companies can utilize when participating in the establishment of these bases. [Seminar Details] ■ Date and Time: May 30 (Thursday) 13:30 - 15:30 (Doors open at 13:00) ■ Venue: JPI Conference Square ■ Address: 5-2-32 Minamiazabu, Minato-ku, Tokyo, Kowa Hiroo Building ■ Instructors: Mizuho Research & Technologies Co., Ltd. 　　　　Social Policy Consulting Department, Social Resilience Promotion Team 　　　　Chief Consultant: Eri Nichiro 　　　　Consultant: Yuki Sato *For more details, please refer to the PDF document or feel free to contact us.

  • Technical Seminar
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Seminar] Ministry of Health, Labour and Welfare: Future Prospects of the Generic Pharmaceutical Industry

[Seminar] Ministry of Health, Labour and Welfare: Future Prospects of the Generic Pharmaceutical Industry

Discussion contents of the "Study Group on the Structure of Industry for Achieving Stable Supply of Generic Pharmaceuticals, etc."

Our company will hold a seminar titled "Ministry of Health, Labour and Welfare: Future Prospects for the Generic Pharmaceutical Industry." Generic pharmaceuticals account for over 50% of the total quantity of prescription drugs and contribute to the improvement of healthcare financing, playing an essential role as social infrastructure. On the other hand, in response to the supply shortage of generic pharmaceuticals stemming from regulatory actions against certain generic pharmaceutical companies, a study group on "the structure of the industry for achieving stable supply of generic pharmaceuticals" was established in July 2023 to engage in broad discussions about the ideal state of the generic pharmaceutical industry and the industrial policies needed to realize it. This seminar will provide detailed explanations not only of the discussions from the study group but also of the future prospects for the generic pharmaceutical industry. 【Seminar Details】 ■ Date and Time: June 13 (Thursday) 13:30 - 15:30 (Doors open at 13:00) ■ Venue: JPI Conference Square ■ Speaker: Ministry of Health, Labour and Welfare Member of the "Study Group on the Structure of the Industry for Achieving Stable Supply of Generic Pharmaceuticals" Director of the Healthcare Division, Corporate Finance Department 6, Development Bank of Japan Mr. Masafumi Nozawa *For more details, please refer to the PDF document or feel free to contact us.

  • Technical Seminar
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Seminar] Current Situation and Challenges of Supply Shortages of Medical Pharmaceuticals

[Seminar] Current Situation and Challenges of Supply Shortages of Medical Pharmaceuticals

Ministry of Health, Labour and Welfare "Stakeholders Meeting on the Stable Supply of Medical Drugs" Hiroyuki Sakamaki, Member, Special Invitation

~ How should regulatory authorities and the industry respond to the shortage of pharmaceuticals? ~ We will hold a business seminar. 【Seminar Details】 ■ Date and Time: May 8, 2025 (Thursday) 09:30 - 11:30 (Doors open at 9:00) ■ Venue: JPI Conference Square ■ Address: 5-2-32 Minamiazabu, Minato-ku, Tokyo, Kowa Hiroo Building ■ Participation Method: In-person, live streaming, archived streaming ■ Speaker: Member of the Ministry of Health, Labour and Welfare's "Stakeholders Meeting on Measures for Ensuring the Stability of Medical Pharmaceuticals" Representative Director of the General Incorporated Association Pharmaceutical Policy Planning P-Cubed Mr. Hiroyuki Sakamaki *For more details, please refer to the PDF document or feel free to contact us.

  • others
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Seminar] Latest Trends in Policies for Stable Supply of Generic Drugs and Corporate Collaboration

[Seminar] Latest Trends in Policies for Stable Supply of Generic Drugs and Corporate Collaboration

Ministry of Health, Labour and Welfare: Points of discussion, issues, and future policy directions regarding the "Study Group on the Structure of Industry for Achieving Stable Supply of Generic Pharmaceuticals."

We will hold a business seminar. 【Seminar Details】 ■ Date and Time: November 4, 2025 (Tuesday) 13:30 - 15:30 (Doors open at 13:00) ■ Venue: JPI Conference Square ■ Address: 5-2-32 Minamiazabu, Minato-ku, Tokyo, Kowa Hiroo Building ■ Participation Method: In-person, live streaming, archived streaming ■ Speaker: Ministry of Health, Labour and Welfare Member of the "Study Group on the Structure of Industry for Realizing Stable Supply of Generic Pharmaceuticals" Masanori Nozawa Director of the Healthcare Division, Corporate Finance Department 6 Japan Policy Investment Bank *For more details, please refer to the PDF document or feel free to contact us.

  • others
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
What is GMP? A clear introduction to its differences from ordinances and ISO, as well as the three principles.

What is GMP? A clear introduction to its differences from ordinances and ISO, as well as the three principles.

This will introduce the basic concepts of GMP, the differences between food and pharmaceutical GMP, and the steps to start implementing GMP.

GMP serves as a standard that underpins the quality of products such as food, pharmaceuticals, and cosmetics. Originally, GMP is a concept that ensures the safety of all "manufacturing." Since GMP is constantly evolving, there are aspects that can be difficult to understand or cumbersome. This article will introduce the fundamental concepts of GMP, the differences between GMP and GMP ordinances, the distinctions between food and pharmaceutical GMP, and the steps to start implementing GMP. *For detailed content of the article, please refer to the link below.*

  • HACCP Management System
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Collaborative Drug Discovery Research Project

Collaborative Drug Discovery Research Project

Fusion of a stabilized peptide tag to antibodies! Production of antibodies that function intracellularly (STAND).

Our company is engaged in collaborative drug discovery research using intracellular antibody STAND technology. Conventional antibodies are unstable and aggregate within cells, rendering them non-functional. The STAND technology is a versatile antibody stabilization technique that can approach disease treatment targets within cells without aggregation in the intracellular environment. Additionally, we also support the development of veterinary pharmaceuticals and research reagents. 【Business Overview】 ■ Drug discovery business using intracellular antibody STAND technology, collaborative drug development business, veterinary pharmaceutical development support, research reagent development support *For more details, please download the PDF or feel free to contact us.

  • reagent
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Seminar] Current Status of Stable Supply of Pharmaceuticals and Government Initiatives

[Seminar] Current Status of Stable Supply of Pharmaceuticals and Government Initiatives

Ministry of Health, Labour and Welfare - Promoting the reform of the industrial structure of generic pharmaceuticals and aiming to strengthen the supply chain.

Our company will hold a business seminar. 【Seminar Details】 ■ Date and Time: September 18, 2025 (Thursday) 16:30 - 18:30 (Doors open at 16:00) ■ Venue: JPI Conference Square ■ Address: 5-2-32 Minamiazabu, Minato-ku, Tokyo, Kowa Hiroo Building ■ Participation Method: In-person, live streaming, archived streaming ■ Instructor: Ministry of Health, Labour and Welfare Medical Affairs Bureau, Medical Industry Promotion and Medical Information Planning Division Director of Pharmaceutical Industry and Venture Support Policy Office Mr. Daisuke Fujii *For more details, please refer to the PDF document or feel free to contact us.

  • others
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Introduction to the Seranostics Business

Introduction to the Seranostics Business

We would like to introduce a project aimed at the integration of imaging diagnosis and treatment using radiopharmaceuticals!

Theranostics, which closely links treatment and diagnosis, is expected to contribute to personalized medicine and the effective use of healthcare costs. By developing therapeutic agents using radioisotopes (RI: radioactive isotopes) that emit alpha particles, a type of radiation, along with companion diagnostic agents, we aim to realize theranostics. We have completed the CRADLE building and established the "Theranostics Production Technology Center." By placing a dedicated department, we will achieve the early supply of alpha-emitting radionuclides from the CRADLE building, while further strengthening collaboration between the drug discovery laboratory located within the same facility and the Chiba factory, thereby accelerating the development of theranostics drug discovery. 【Functions of the facility】 ■ Production of 225Ac and PET radionuclides ■ Handling of 177Lu and 211At, among others ■ Production of investigational drugs ■ Production of research-use RIs *For more details, please refer to the PDF document or feel free to contact us.

  • Other contract manufacturing
  • Other contract services
  • Pharmaceutical intermediate manufacturing services
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Features of Aptamers

Features of Aptamers

Fits the shape of proteins! Nucleic acid molecules that can inhibit or regulate.

We would like to introduce the features of the "aptamer" that we handle. Single-stranded nucleic acids form various three-dimensional structures according to their sequences. Utilizing this structural capability, these nucleic acid molecules can bind to target proteins and inhibit or regulate their functions. Please feel free to contact us when you need assistance. 【Features】 ■ Creates a three-dimensional structure that fits the shape of the protein for binding, known as "shape capture." *For more details, please refer to the PDF materials or feel free to contact us.

  • Pharmaceutical Intermediates
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Examples of Analytical Methods in Biologics/Antibody Pharmaceuticals Held on February 16

Examples of Analytical Methods in Biologics/Antibody Pharmaceuticals Held on February 16

Introduction to analytical methods used for quality control of antibody pharmaceuticals! Online seminar introduction.

We are pleased to announce that our company will be hosting the third installment of our webinar series titled "Case Studies of Analytical Methods in Biologics/Antibody Drugs." In light of the growing development of biopharmaceuticals, our company has been strengthening its biopharmaceutical development capabilities. During this time, we have received numerous analytical project requests from our customers. In this webinar, we will introduce analytical methods used for quality control, using antibody drugs as examples, based on the knowledge we have cultivated thus far. We sincerely look forward to your participation. 【Overview】 ■ Date and Time: February 16 (Thursday) 11:00 AM - 11:30 AM ■ Format: Online (Teams) ■ Participation: Free *For more details, please refer to the related links or feel free to contact us.

  • Seminar
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Reagents, scientific instruments, pharmaceuticals

Reagents, scientific instruments, pharmaceuticals

Leave it to us for products related to research and development, including bio, genome, nanotechnology, with a core focus on reagent sales.

Our company has been providing products such as reagents, clinical testing agents, industrial chemicals, and scientific instruments to contribute to various users, including academic research institutions, industrial sectors, and the medical field, as a comprehensive reagent dealer. As a support industry for research and development, we will respond to advancements in science and technology and technological innovation by providing the information our customers seek and promoting proposal-based sales. Please feel free to contact us with any requests. 【Business Areas】 ■ Bio ■ Chemical ■ Clinical Testing ■ Quality Control and Analysis *For more details, please download the PDF or feel free to contact us.

  • Other contract services
  • Clinical Development Systems
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Molecular basis of small nucleic acids that control gene expression and their application in pharmaceuticals.

Molecular basis of small nucleic acids that control gene expression and their application in pharmaceuticals.

Keywords: microRNA, viral defense mechanisms, cell death due to viral infection, siRNA, nucleic acid medicines

mRNA is RNA that contains information for protein synthesis, but there are also many non-coding RNAs in the cell that do not carry messages. We have been elucidating the mechanisms by which immune responses to RNA virus infections are regulated by small non-coding RNAs called microRNAs. Understanding this mechanism may contribute to the development of novel nucleic acid medicines. Additionally, while siRNA also suppresses the expression of mRNA, siRNA has a suppressive effect on a single gene, whereas microRNA acts on entire specific gene groups. Although there are currently no nucleic acid medicines utilizing microRNA, we are hopeful that if the mechanisms of their action in virus-infected cells are clarified, the potential for nucleic acid medicines will expand even further.

  • others
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Techniques for Differentiating Strong Patent Specifications and Claims for Antibody Pharmaceutical Patents

Techniques for Differentiating Strong Patent Specifications and Claims for Antibody Pharmaceutical Patents

Which is advantageous for identification: antigen, CDR, cross-reactivity, or hybridoma?

★What constitutes a strong patent specification and claims when acquiring rights for antibody drugs? ★Along with essential practical knowledge, we will teach you claim techniques that your company may not know, incorporating exercises! 【Instructor】Akihiko Okuno, Representative Employee, SK Patent Firm, Patent Attorney 【Venue】Tekuno Kawasaki, 5th Floor, Room 5 Training 【Kanagawa, Musashi-Mizonokuchi Station】 【Date and Time】November 29, 2010 (Monday) 13:00–16:00 【Lecture ends at 16:00. 16:00-16:30: Free Time Q&A】

  • Company：AndTech
  • Price：10,000 yen-100,000 yen
  • Technical Seminar
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Trends in the Generic Pharmaceutical Industry and Basic Knowledge of Patents and Patent Strategies

Trends in the Generic Pharmaceutical Industry and Basic Knowledge of Patents and Patent Strategies

★Utilizing patents as a means of differentiation for generic pharmaceuticals! ★What is your perspective on the invalidation trials conducted by generic pharmaceutical companies as a business strategy?

Speaker Mr. Ichiro Tasaka, Patent Attorney, Nagasawa Patent Office/Tokyo Marunouchi Law Office Target Audience: Engineers and researchers interested in generic development strategies, patent analysis methods, etc. Venue RYUKA Intellectual Property Hall, 22F Seminar Room [Tokyo, Shinjuku] 3-minute walk from "Shinjuku" Station on JR, Odakyu Odawara Line, Keio Line, and Tokyo Metro Marunouchi Line Date and Time November 21, 2011 (Monday) 13:30-16:30 Capacity: 30 people *Registration will close once full. Please apply early. Participation Fee [Early Bird Discount Price] 19,950 yen per person (including tax and textbook fee) *Limited to Tech-Zone members who apply by November 7. Membership registration is free. *After November 7, the [Regular Price] will be 23,100 yen per person (including tax and textbook fee).

  • Company：AndTech
  • Price：10,000 yen-100,000 yen
  • Technical Seminar
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
【Industry-Specific Utilization Methods】Pharmaceuticals

【Industry-Specific Utilization Methods】Pharmaceuticals

We are introducing the three key points of GDP and two transportation methods corresponding to GDP!

In the pharmaceutical industry, it has become necessary to respond to GDP (Good Distribution Practice), which expands to include storage and transportation in the distribution process, as a complement to the conventional GMP (Good Manufacturing Practice) standards for manufacturing and quality control. Emphasis is placed on ensuring quality throughout the distribution process, with particular importance placed on temperature control. It is required that proper temperature management is maintained from the time products leave the manufacturing facility until they reach the patient. Wacon will assist you in complying with GDP using refrigerated boxes. *For more detailed information, please refer to the related links. For further details, you can download the PDF or feel free to contact us.*

  • Food transport materials (cooling, heat retention, etc.)
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Web Seminar: Characterization of Antibody-Related Pharmaceuticals

Web Seminar: Characterization of Antibody-Related Pharmaceuticals

Toray Research Center × SciEx × Protein Metrics Jointly Hosted Web Seminar (Characterization of Antibody-Related Pharmaceuticals)

Analysis of the Characteristics of Antibody-Related Pharmaceuticals – Detailed Modification Analysis Including Charge Variants and Glycans Using LC-MS and icIEF-UV/MS – < Event Overview > Date and Time: January 16, 2025 (Thursday) 15:00 - 16:00 Format: Online (Zoom) 1. Analysis of Charge Heterogeneity of Antibody-Related Pharmaceuticals Using the Intabio ZT System (Ryo Yokoyama, AB Sciex Co., Ltd.) 2. Case Studies of Characteristic Analysis of Biopharmaceuticals Using Mass Spectrometry (Satoko Ota, Toray Research Center, Inc.) 3. Improving Work Efficiency in Protein Pharmaceutical Analysis Using MS Data Analysis Software Byos (Ayako Kurimoto, Protein Metrics) ◆ Detailed Page for This Webinar https://proteinmetrics.com/%e6%8a%97%e4%bd%93%e9%96%a2%e9%80%a3%e5%8c%bb%e8%96%ac%e5%93%81%e3%81%ae%e7%89%b9%e6%80%a7%e8%a7%a3%e6%9e%90/

  • others
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Service Example] Major Pharmaceutical Company J

[Service Example] Major Pharmaceutical Company J

We will introduce examples of providing extensive support for the preparation of materials for internal controls and lectures for stakeholders, as well as support for the internal implementation of new business launches!

We would like to introduce a case where comprehensive project management was implemented for Company J, a major pharmaceutical company, while considering the legal regulations surrounding pharmaceutical sales. The company was exploring the launch of a new e-commerce platform in order to broaden its user base and achieve further sales growth. After the service was introduced, the synchronization of member information registered on the existing site with the e-commerce system was addressed, allowing purchasing behavior on the e-commerce platform to be reflected in the existing customer database in real-time. We provided extensive support for necessary e-commerce operations both before and after the release. [Challenges] - The company was exploring the launch of a new e-commerce platform to broaden its user base and achieve further sales growth. - There were several concerns regarding the construction of the e-commerce platform, including the specific regulations of the Pharmaceutical and Medical Device Act (formerly the Pharmaceutical Affairs Law) related to pharmaceutical e-commerce and the integration of member information registered on the existing site. *For more details, please refer to the related links or feel free to contact us.*

  • Internal Control and Operational Management
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
OTC Pet Medicine Market - Global Industry Analysis, Forecast for 2032

OTC Pet Medicine Market - Global Industry Analysis, Forecast for 2032

It is predicted to reach 9.95 billion US dollars in 2025 and grow to 13.27 billion US dollars by 2032.

Fairfield Market Research is a research company that publishes highly relevant market data and insightful detailed reports. The global OTC pet pharmaceuticals market is experiencing significant growth, driven by an increase in pet ownership and substantial advancements in pet healthcare products. Fueled by the rising importance of pet health and wellness, the market is expected to grow at a compound annual growth rate (CAGR) of 4.20% throughout the forecast period. The market size is projected to reach USD 9.95 billion by 2025, with further growth anticipated to USD 13.27 billion by 2032. This growth underscores the trend of pets increasingly being regarded as family members and the deepening bond between humans and pets. This report provides a detailed analysis of the OTC pet pharmaceuticals market. It analyzes the market by product type, pet type, pharmaceutical form, and sales channel, and also discusses the strategies and challenges of key market players in detail.

  • others
  • others
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Pharmaceutical Products in Genetic Engineering

[Research Material] The Global Market for Pharmaceutical Products in Genetic Engineering

World Market for Genetic Engineering Pharmaceuticals: Monoclonal Antibodies, Recombinant Human Erythropoietin, Recombinant Human Interferon, Recombinant Human Growth ...

This research report (Global Genetic Engineering Drug Market) investigates and analyzes the current status and outlook for the global market of genetic engineering pharmaceuticals over the next five years. It includes information on the overview of the global genetic engineering pharmaceuticals market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the genetic engineering pharmaceuticals market focus on monoclonal antibodies, recombinant human erythropoietin, recombinant human interferon, recombinant human growth hormone, and recombinant human insulin, while the segments by application cover medical, research, industrial, agricultural, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for genetic engineering pharmaceuticals. The report also includes the market share of major companies in genetic engineering pharmaceuticals, product and business overviews, and sales performance.

  • Other services
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
The global market for recombinant human erythropoietin (rhEPO)

The global market for recombinant human erythropoietin (rhEPO)

World Market for Recombinant Human Erythropoietin (rhEPO): ESRD, Cancer, HIV, Wound & Neurological Diseases, Hospitals, Retail Pharmacies

This research report (Global Recombinant Human Erythropoietin (rhEPO) Market) investigates and analyzes the current status and outlook for the global market of recombinant human erythropoietin (rhEPO) over the next five years. It includes information on the global recombinant human erythropoietin (rhEPO) market overview, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for recombinant human erythropoietin (rhEPO) by type target ESRD, cancer, HIV, and wound/neuro diseases, while the segments by application focus on hospitals and retail pharmacies. The regional segments calculate the market size of recombinant human erythropoietin (rhEPO) by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in recombinant human erythropoietin (rhEPO), product and business overviews, and sales performance.

  • Other services
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Prescription Drugs

[Research Material] The Global Market for Prescription Drugs

World Market for Prescription Pharmaceuticals: PIA, PAA, CUPM, PDA, SAPM, Consumers under 18, Consumers aged 19-44, Consumers aged 45-64 ...

This research report (Global Compounding Pharmacy Market) investigates and analyzes the current state of the global compounding pharmacy market and its outlook for the next five years. It includes information on the overview of the global compounding pharmacy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the compounding pharmacy market focus on PIA, PAA, CUPM, PDA, and SAPM, while the segments by application target consumers under 18 years old, consumers aged 19-44, consumers aged 45-64, and consumers aged 65 and older. The regional segments calculate the market size of compounding pharmacies by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the compounding pharmacy sector, product and business overviews, and sales performance.

  • Other services
  • Pharmaceuticals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.